Cliff Asness's ROIV Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 5.95 M shares of Roivant Sciences Ltd. (ROIV) worth $161.64 M, representing 0.07% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ROIV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 5.07 M shares. Largest reduction occurred in Q4 2024, reducing 131,422 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +5.07 M | Add 575.19% | 5.95 M | $27.18 |
| Q4 2025 | +810,402 | Add 1151.61% | 880,773 | $21.56 |
| Q3 2025 | +70,371 | New Buy | 70,371 | $15.05 |
| Q4 2024 | -131,422 | Sold Out | 0 | $0.00 |
| Q3 2024 | -73,512 | Reduce 35.87% | 131,422 | $11.51 |
| Q2 2024 | -96,894 | Reduce 32.10% | 204,934 | $10.57 |
| Q1 2024 | +214,884 | Add 247.15% | 301,828 | $10.43 |
| Q4 2023 | -27,665 | Reduce 24.14% | 86,944 | $11.20 |
| Q3 2023 | +7,489 | Add 6.99% | 114,609 | $11.68 |
| Q2 2023 | +107,120 | New Buy | 107,120 | $10.08 |
Cliff Asness's Roivant Sciences Investment FAQs
Cliff Asness first purchased Roivant Sciences Ltd. (ROIV) in Q2 2023, acquiring 107,120 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Roivant Sciences Ltd. (ROIV) for 10 quarters since Q2 2023.
Cliff Asness's largest addition to Roivant Sciences Ltd. (ROIV) was in Q1 2026, adding 5,946,858 shares worth $161.64 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 5,946,858 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $161.64 M.
As of the Q1 2026 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.07% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Roivant Sciences Ltd. (ROIV) was 5,946,858 shares, as reported at the end of Q1 2026.